Gamma knife surgery for brain metastases from ovarian cancer.

Gamma knife surgery for brain metastases from ovarian cancer.


numerous tables including:

Table 1 Patient characteristics of 16 patients with 119 brain metastases

Conclusions

Brain metastases from ovarian cancer are rare, but their incidence is increasing as patient survival has been extended by successful platinum-based chemotherapy and improved imaging techniques have enabled the identification of smaller lesions. In our study, the median survival from brain metastases was 12.5 months, and the local control rate was 86.4 %. The KPS and total volume of brain metastases were important factors predictive of survival. Our results suggest that GKS is an acceptable therapy for brain metastases from ovarian cancer. 

Conflicts of interest  

None.

Open Access